CRP and pachyonychia congenita: The existing literature also suggests that CRP could hold a function as a prognostic marker for metastasised or androgen-independent PC (Beer et al, 2008; Nakashima et al, 2008), although the overall serum CRP concentrations of patients with PC seem not to be increased compared to those of healthy controls (Platz et al, 2004; Siemes et al, 2006; Trichopoulos et al, 2006; Heikkila et al, 2007, 2008).